98 related articles for article (PubMed ID: 25524433)
1. Persistence and adherence to oral antidiabetics: a population-based cohort study.
Simard P; Presse N; Roy L; Dorais M; White-Guay B; Räkel A; Perreault S
Acta Diabetol; 2015 Jun; 52(3):547-56. PubMed ID: 25524433
[TBL] [Abstract][Full Text] [Related]
2. Difficulty adhering to antidiabetic treatment: factors associated with persistence and compliance.
Guénette L; Moisan J; Breton MC; Sirois C; Grégoire JP
Diabetes Metab; 2013 May; 39(3):250-7. PubMed ID: 23523643
[TBL] [Abstract][Full Text] [Related]
3. Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study.
Grégoire JP; Sirois C; Blanc G; Poirier P; Moisan J
Value Health; 2010; 13(6):820-8. PubMed ID: 21054658
[TBL] [Abstract][Full Text] [Related]
4. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
[TBL] [Abstract][Full Text] [Related]
5. Important treatment gaps in vascular protection for the elderly after type 2 diabetes therapy initiation.
Guénette L; Breton MC; Hamdi H; Grégoire JP; Moisan J
Can J Cardiol; 2013 Dec; 29(12):1593-8. PubMed ID: 24183301
[TBL] [Abstract][Full Text] [Related]
6. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Oladapo AO; Barner JC; Rascati KL; Strassels SA
Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
[TBL] [Abstract][Full Text] [Related]
7. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.
Xing S; Calip GS; Leow AD; Kim S; Schumock GT; Touchette DR; Lee TA
J Diabetes Complications; 2018 May; 32(5):492-500. PubMed ID: 29544744
[TBL] [Abstract][Full Text] [Related]
8. Impact of cancer diagnosis on persistence of oral antidiabetic drugs.
Létinier L; Mansiaux Y; Pariente A; Fourrier-Réglat A
Diabetes Res Clin Pract; 2018 May; 139():323-330. PubMed ID: 29526679
[TBL] [Abstract][Full Text] [Related]
9. Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident Diabetes.
Gatwood JD; Chisholm-Burns M; Davis R; Thomas F; Potukuchi P; Hung A; Kovesdy CP
J Manag Care Spec Pharm; 2018 Apr; 24(4):379-389. PubMed ID: 29578849
[TBL] [Abstract][Full Text] [Related]
10. An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents.
O'Shea MP; Teeling M; Bennett K
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1336-44. PubMed ID: 24142802
[TBL] [Abstract][Full Text] [Related]
11. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
12. Comparison of persistence and adherence between fixed-dose combinations and two-pill combinations in Japanese patients with type 2 diabetes.
Nishimura R; Kato H; Kisanuki K; Oh A; Onishi Y; Guelfucci F; Shimasaki Y
Curr Med Res Opin; 2019 May; 35(5):869-878. PubMed ID: 30460858
[TBL] [Abstract][Full Text] [Related]
13. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.
Sacks NC; Burgess JF; Cabral HJ; Pizer SD; McDonnell ME
J Gen Intern Med; 2013 Jul; 28(7):876-85. PubMed ID: 23404199
[TBL] [Abstract][Full Text] [Related]
14. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
[TBL] [Abstract][Full Text] [Related]
16. Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibitors: A Nationwide Retrospective Cohort Study.
Ofori-Asenso R; Liew D; Lalic S; Mazidi M; Magliano DJ; Ademi Z; Bell JS; Ilomaki J
Adv Ther; 2019 Nov; 36(11):3265-3278. PubMed ID: 31482509
[TBL] [Abstract][Full Text] [Related]
17. Association Between Metformin Adherence and All-Cause Mortality Among New Users of Metformin: A Nested Case-Control Study.
Simard P; Presse N; Roy L; Dorais M; White-Guay B; Räkel A; Perreault S
Ann Pharmacother; 2018 Apr; 52(4):305-313. PubMed ID: 29144162
[TBL] [Abstract][Full Text] [Related]
18. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
[TBL] [Abstract][Full Text] [Related]
19. Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens.
Sambamoorthi U; Deb A; Zhou S; Garg R; Fan T; Boss A
J Diabetes Res; 2016; 2016():5374931. PubMed ID: 27761472
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression.
Lunghi C; Zongo A; Moisan J; Grégoire JP; Guénette L
J Diabetes Complications; 2017 Jul; 31(7):1200-1206. PubMed ID: 28325698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
